Our data, including histological analysis, gene expression analysis, and cytokines secretion studies, suggest that HY7718 suppresses inflammatory responses by regulating the TLR/MyD88/NF-κB signaling pathway in IBD. Here, NFKB1 is linked to inflammatory bowel disease.